Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06411665
PHASE4

Effect of Oliceridine Analgesia on Postoperative Nause and Vomiting

Sponsor: Peking University First Hospital

View on ClinicalTrials.gov

Summary

Postoperative nausea and vomiting (PONV) is common after surgery and impede rapid recovery after surgery. Patients who undergo laparoscopic colorectal surgery are more likely to develop PONV due to the pneumoperitoneum, interruption of gastrointestinal system, delay of oral feeding, and nasogastric catheterization, as well as postoperative opioid analgesic requirement to control acute pain. Oliceridine is a novel selective μ-opioid agonist. It stimulates G protein signalling but is markedly less potent than morphine for β-arrestin recruitment; the latter contributes to opioid-related adverse events including PONV. It is postulated that G protein-biased agonists may deliver effective analgesia with fewer opioid-related adverse events. This randomized trial aimed to investigate whether oliceridine for patient-controlled analgesia can decrease the incidence of PONV in patients recovering from laparoscopic colorectal surgery.

Official title: Effect of Oliceridine Analgesia on Postoperative Nause and Vomiting in Laparoscopic Colorectal Surgery: A Randomized Trial

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

252

Start Date

2024-07-02

Completion Date

2026-12

Last Updated

2024-10-08

Healthy Volunteers

No

Interventions

DRUG

Oliceridine

Patient-controlled intravenous analgesia with oliceridine for up to 3 days after surgery.

DRUG

Morphine

Patient-controlled intravenous analgesia with morphine for up to 3 days after surgery.

Locations (1)

Dong-Xin Wang

Beijing, China